Search PubMed⌕ Search

Biomedical subjects

Guilherme G Verocai

Publications and source records attributed to Guilherme G Verocai.

2 recordsLinked to original sources

ves1α genes expression is the major determinant of Babesia bovis-infected erythrocytes cytoadhesion to endothelial cells.

Babesia bovis causes the most pathogenic form of babesiosis in cattle, resulting in high mortality in naive adults. This parasite invades red blood cells (RBCs) within the bovine hosts where they multiply and produce clinical disease. Babesia bovis exports numerous proteins into invaded RBCs changing its properties. Thus, the infected RBCs (iRBCs) are capable to cytoadhere in the microvasculature of internal organs and brain, leading to respiratory distress, neurologic signs, and mortality. Variant Erythrocyte Surface Antigen 1 (VESA1) is one of those exported proteins by B. bovis which represents a major virulence factor due to its central role in immune evasion by antigenic variation and intravascular parasite sequestration. VESA1 is a heterodimer protein encoded by ves1α and ves1β multigene family and localized on the ridges, the focal point for cytoadhesion. To gain further insights into the molecular mechanisms of cytoadhesion of B. bovis, we panned the parasites with bovine brain microvasculature endothelial cells, which resulted in obtaining several clones with different cytoadherence abilities. The transcriptome analysis of 2 high and 2 low cytoadherent clones revealed that ves1α sequences were diversified, likely resulting from genomic recombination. On the other hand, ves1β sequences were almost identical among these 4 clones. Insertion and expression of ves1α of a clone with high binding into ef-1α locus of a low binding clone increased cytoadherence confirming the role of ves1α suggested by our transcriptome data. Whole genome sequencing of cytoadherent clones revealed active locus of ves1 on chromosome 2. These results suggest that VESA1a proteins encoded by ves1α genes determine the cytoadherence strength of B. bovis and they are in the active site for recombination.

Animals↗

[Miticidal efficacy of thiabendazole against Otodectes cynotis (Hering, 1838) in dogs].

The aim of the present study was to evaluate the efficacy of thiabendazole on the treatment of Otodectes cynotis infestations in dogs. Ten naturally infested beagle dogs were used. The mites were diagnosed through otoscopy. Dogs were examined three days before treatment (day -3) and on the treatment day (day 0). They were randomly divided into two groups, five animals for the control group and five for the treated. During seven days, was applied in both ears of the treated dogs 1ml of the thiabendazole 5% solution, which correspond to 50mg of the product. All animals were reexamined through otoscopy on days +1, +3, +7, +10, +17, +24 and +31. The dogs on the control group showed mites in both ears during the whole period of observation. On the treated group the efficacy varied from 20% on the left ear to 80% on the right ear, on the first day after treatment. On days +3, +7, +10, +17, +24 and +31 the medium efficacy was 100% on both ears. The thiabendazole was efficient on the elimination of O. cynotis in dogs when used on the dose of 50mg per ear during seven following days.

Animals↗